These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19853660)

  • 1. Guidelines to cell engineering for monoclonal antibody production.
    Rita Costa A; Elisa Rodrigues M; Henriques M; Azeredo J; Oliveira R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):127-38. PubMed ID: 19853660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.
    Butler M
    Appl Microbiol Biotechnol; 2005 Aug; 68(3):283-91. PubMed ID: 15834715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid protein production using CHO stable transfection pools.
    Ye J; Alvin K; Latif H; Hsu A; Parikh V; Whitmer T; Tellers M; de la Cruz Edmonds MC; Ly J; Salmon P; Markusen JF
    Biotechnol Prog; 2010; 26(5):1431-7. PubMed ID: 20564356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological progresses in monoclonal antibody production systems.
    Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R
    Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upstream processes in antibody production: evaluation of critical parameters.
    Jain E; Kumar A
    Biotechnol Adv; 2008; 26(1):46-72. PubMed ID: 17920803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody production.
    Birch JR; Racher AJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):671-85. PubMed ID: 16822577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fed-batch bioreactor process scale-up from 3-L to 2,500-L scale for monoclonal antibody production from cell culture.
    Yang JD; Lu C; Stasny B; Henley J; Guinto W; Gonzalez C; Gleason J; Fung M; Collopy B; Benjamino M; Gangi J; Hanson M; Ille E
    Biotechnol Bioeng; 2007 Sep; 98(1):141-54. PubMed ID: 17657776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting higher yields of monoclonal antibody in culture.
    Kundu PK; Prasad NS; Electricwala SE; Varma R; Datta D
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):155-71. PubMed ID: 10225044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?
    Dinnis DM; James DC
    Biotechnol Bioeng; 2005 Jul; 91(2):180-9. PubMed ID: 15880827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA stability and antibody production in CHO cells: improvement through gene optimization.
    Hung F; Deng L; Ravnikar P; Condon R; Li B; Do L; Saha D; Tsao YS; Merchant A; Liu Z; Shi S
    Biotechnol J; 2010 Apr; 5(4):393-401. PubMed ID: 20222103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level protein expression in scalable CHO transient transfection.
    Ye J; Kober V; Tellers M; Naji Z; Salmon P; Markusen JF
    Biotechnol Bioeng; 2009 Jun; 103(3):542-51. PubMed ID: 19199356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process technology for production and recovery of heterologous proteins with Pichia pastoris.
    Jahic M; Veide A; Charoenrat T; Teeri T; Enfors SO
    Biotechnol Prog; 2006; 22(6):1465-73. PubMed ID: 17137292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scale-up of monoclonal antibody purification processes.
    Aldington S; Bonnerjea J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):64-78. PubMed ID: 17224311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Chinese hamster ovary cell stability during repeated batch culture for large-scale antibody production.
    Kaneko Y; Sato R; Aoyagi H
    J Biosci Bioeng; 2010 Mar; 109(3):274-80. PubMed ID: 20159577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.